المؤلفون: Roberto G; Agenzia Regionale di Sanità della Toscana, Firenze, Italy., Spini A; Department of Medical Science, Surgery and Neuroscience, University of Siena, and Azienda Ospedaliera Universitaria Senese, Siena, Italy., Bartolini C; Agenzia Regionale di Sanità della Toscana, Firenze, Italy., Moscatelli V; Department of Life sciences, University of Siena, Siena, Italy., Barchielli A; Istituto per lo Studio la Prevenzione e la Rete Oncologica, Firenze, Italy., Paoletti D; Farmacia Oncologica, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Giorgi S; Farmacia Oncologica, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Fabbri A; Unit of Hematology, Azienda Ospedaliera Universitaria Senese and University of Siena, Siena, Italy., Bocchia M; Unit of Hematology, Azienda Ospedaliera Universitaria Senese and University of Siena, Siena, Italy., Donnini S; Department of Life sciences, University of Siena, Siena, Italy., Gini R; Agenzia Regionale di Sanità della Toscana, Firenze, Italy., Ziche M; Department of Medical Science, Surgery and Neuroscience, University of Siena, and Azienda Ospedaliera Universitaria Senese, Siena, Italy.

المصدر: PloS one [PLoS One] 2020 Mar 12; Vol. 15 (3), pp. e0229973. Date of Electronic Publication: 2020 Mar 12 (Print Publication: 2020).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*administration & dosage , Drug Utilization/*statistics & numerical data , Infections/*epidemiology , Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy , Lymphoma, Non-Hodgkin/*drug therapy , Rituximab/*administration & dosage, Administration, Intravenous ; Administrative Claims, Healthcare/statistics & numerical data ; Adolescent ; Adult ; Aged ; Antineoplastic Agents, Immunological/adverse effects ; Databases, Factual/statistics & numerical data ; Female ; Follow-Up Studies ; Humans ; Infections/chemically induced ; Infections/immunology ; Italy/epidemiology ; Kaplan-Meier Estimate ; Leukemia, Lymphocytic, Chronic, B-Cell/immunology ; Leukemia, Lymphocytic, Chronic, B-Cell/mortality ; Longitudinal Studies ; Lymphoma, Non-Hodgkin/immunology ; Lymphoma, Non-Hodgkin/mortality ; Male ; Middle Aged ; Pharmacy Service, Hospital/statistics & numerical data ; Retrospective Studies ; Rituximab/adverse effects ; Time Factors ; Treatment Outcome ; Young Adult

المؤلفون: Cencini E; a Unit of Hematology , Azienda Ospedaliera Universitaria Senese , Siena , Italy.; b Unit of Hematology , University of Siena , Siena , Italy., Fabbri A; a Unit of Hematology , Azienda Ospedaliera Universitaria Senese , Siena , Italy., Schiattone L; a Unit of Hematology , Azienda Ospedaliera Universitaria Senese , Siena , Italy., Gentili F; c Department of Medical, Surgical and Neuro Sciences, Diagnostic Imaging , Azienda Ospedaliera Universitaria Senese , Siena , Italy., Mazzei MA; c Department of Medical, Surgical and Neuro Sciences, Diagnostic Imaging , Azienda Ospedaliera Universitaria Senese , Siena , Italy., Bocchia M; a Unit of Hematology , Azienda Ospedaliera Universitaria Senese , Siena , Italy.; b Unit of Hematology , University of Siena , Siena , Italy.

المصدر: Acta clinica Belgica [Acta Clin Belg] 2018 Dec; Vol. 73 (6), pp. 408-412. Date of Electronic Publication: 2017 Dec 06.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 0370306 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2295-3337 (Electronic) Linking ISSN: 17843286 NLM ISO Abbreviation: Acta Clin Belg Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, B-Cell*/diagnostic imaging , Lymphoma, B-Cell*/drug therapy , Lymphoma, B-Cell*/pathology , Lymphoma, B-Cell*/surgery, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Rituximab/*therapeutic use, Aged ; Bleomycin/therapeutic use ; Cyclophosphamide/therapeutic use ; Etoposide/therapeutic use ; Humans ; Male ; Mitoxantrone/therapeutic use ; Prednisone/therapeutic use ; Urinary Bladder/diagnostic imaging ; Urinary Bladder/pathology ; Urinary Bladder/surgery ; Urinary Bladder Neoplasms/diagnostic imaging ; Urinary Bladder Neoplasms/drug therapy ; Urinary Bladder Neoplasms/pathology ; Urinary Bladder Neoplasms/surgery ; Vincristine/therapeutic use

SCR Protocol: VNCOP-B protocol

المؤلفون: Cencini E; a Unit of Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena , Siena , Italy., Puccini B; b Hematology Department , Azienda Ospedaliera Universitaria Careggi , Firenze , Italy., Rigacci L; b Hematology Department , Azienda Ospedaliera Universitaria Careggi , Firenze , Italy., Fabbri A; a Unit of Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena , Siena , Italy., Kovalchuk S; b Hematology Department , Azienda Ospedaliera Universitaria Careggi , Firenze , Italy., Mannelli L; b Hematology Department , Azienda Ospedaliera Universitaria Careggi , Firenze , Italy., Benelli G; b Hematology Department , Azienda Ospedaliera Universitaria Careggi , Firenze , Italy., Carfagno T; c Radiotherapy Department , Azienda Ospedaliera Universitaria Senese , Siena , Italy., Simontacchi G; d Radiotherapy Department , Azienda Ospedaliera Universitaria Careggi , Firenze , Italy., Bocchia M; a Unit of Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena , Siena , Italy., Bosi A; b Hematology Department , Azienda Ospedaliera Universitaria Careggi , Firenze , Italy.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2018 Jun; Vol. 59 (6), pp. 1420-1426. Date of Electronic Publication: 2017 Oct 10.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Radiotherapy*/methods, Antineoplastic Agents, Immunological/*therapeutic use , Lymphoma, Follicular/*pathology , Lymphoma, Follicular/*therapy , Rituximab/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Agents, Immunological/adverse effects ; Chemoradiotherapy ; Female ; Humans ; Lymphoma, Follicular/mortality ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Staging ; Retrospective Studies ; Rituximab/administration & dosage ; Rituximab/adverse effects ; Survival Analysis ; Treatment Outcome ; Young Adult

المؤلفون: Cencini E; Haematology Unit, Azienda Ospedaliera Universitaria Senese, Viale Bracci, 16, 53100, Siena, Italy. cencioema@libero.it.; University of Siena, Siena, Italy. cencioema@libero.it., Fabbri A; Haematology Unit, Azienda Ospedaliera Universitaria Senese, Viale Bracci, 16, 53100, Siena, Italy., Lauria F; University of Siena, Siena, Italy., Bocchia M; Haematology Unit, Azienda Ospedaliera Universitaria Senese, Viale Bracci, 16, 53100, Siena, Italy.; University of Siena, Siena, Italy.

المصدر: Annals of hematology [Ann Hematol] 2018 May; Vol. 97 (5), pp. 821-829. Date of Electronic Publication: 2018 Jan 16.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Lymphoma, B-Cell, Marginal Zone/*drug therapy , Mitoxantrone/*administration & dosage , Rituximab/*administration & dosage , Stomach Neoplasms/*drug therapy , Vidarabine/*analogs & derivatives, Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cohort Studies ; Female ; Hematologic Diseases/chemically induced ; Hematologic Diseases/diagnosis ; Humans ; Lymphoma, B-Cell, Marginal Zone/diagnosis ; Male ; Middle Aged ; Mitoxantrone/adverse effects ; Retrospective Studies ; Rituximab/adverse effects ; Stomach Neoplasms/diagnosis ; Time Factors ; Treatment Outcome ; Vidarabine/administration & dosage ; Vidarabine/adverse effects

المؤلفون: Cencini E; Haematology Unit, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy., Fabbri A; Haematology Unit, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy., Bocchia M; Haematology Unit, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy.

المصدر: British journal of haematology [Br J Haematol] 2017 Mar; Vol. 176 (5), pp. 831-833. Date of Electronic Publication: 2016 Feb 23.

نوع المنشور: Letter

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*therapeutic use , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Hodgkin Disease/*drug therapy , Rituximab/*therapeutic use, Adult ; Aged ; Antineoplastic Agents, Immunological/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Bleomycin/pharmacology ; Bleomycin/therapeutic use ; Dacarbazine/pharmacology ; Dacarbazine/therapeutic use ; Doxorubicin/pharmacology ; Doxorubicin/therapeutic use ; Female ; Hodgkin Disease/pathology ; Humans ; Male ; Middle Aged ; Rituximab/pharmacology ; Vinblastine/pharmacology ; Vinblastine/therapeutic use ; Young Adult

SCR Protocol: ABVD protocol

المؤلفون: Cencini E; a Unit of Hematology, University Hospital of Siena , Siena , Italy.; b University of Siena , Siena , Italy., Fabbri A; a Unit of Hematology, University Hospital of Siena , Siena , Italy., Schiattone L; a Unit of Hematology, University Hospital of Siena , Siena , Italy., Bartalucci G; a Unit of Hematology, University Hospital of Siena , Siena , Italy., Bocchia M; a Unit of Hematology, University Hospital of Siena , Siena , Italy.; b University of Siena , Siena , Italy.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2015; Vol. 56 (10), pp. 2997-8. Date of Electronic Publication: 2015 Mar 23.

نوع المنشور: Journal Article; Comment

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Radiotherapy*, Antineoplastic Agents/*therapeutic use , Lymphoma, Follicular/*pathology , Lymphoma, Follicular/*therapy , Rituximab/*therapeutic use, Female ; Humans ; Male

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.